Cargando…
Identification of FDA-Approved Drugs with Activity against Stationary Phase Bartonella henselae
Bartonella henselae can cause various infections in humans, ranging from benign and self-limiting diseases to severe and life-threatening diseases as well as persistent infections that are difficult to treat. To develop more effective treatments for persistent Bartonella infections, in this study, w...
Autores principales: | Li, Tingting, Feng, Jie, Xiao, Shuzhen, Shi, Wanliang, Sullivan, David, Zhang, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628006/ https://www.ncbi.nlm.nih.gov/pubmed/31035691 http://dx.doi.org/10.3390/antibiotics8020050 |
Ejemplares similares
-
Essential Oils with High Activity against Stationary Phase Bartonella henselae
por: Ma, Xiao, et al.
Publicado: (2019) -
Effect of different drugs and drug combinations on killing stationary phase and biofilms recovered cells of Bartonella henselae in vitro
por: Zheng, Xiaoyan, et al.
Publicado: (2020) -
Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library
por: Feng, Jie, et al.
Publicado: (2014) -
Identification of essential oils with activity against stationary phase Staphylococcus aureus
por: Xiao, Shuzhen, et al.
Publicado: (2020) -
etymologia: Bartonella henselae
Publicado: (2008)